APOE gene ɛ4 allele (388C‐526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population
Open Access
- 27 July 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (9) , e23925
Abstract
Objective: To analyze the relationship of Apolipoprotein E (APOE) and solute carrier organic anion transporter family member 1B1 (SLCO1B1) gene polymorphisms with coronary artery disease (CAD).Methods: 1,129 CAD patients and 1,014 non‐CAD controls were included in the study, and relevant information and medical records were collected. The single‐nucleotide polymorphisms (SNPs) were analyzed, including rs429358, rs7412 in APOE gene and rs2306283, rs4149056 in SLCO1B1 gene.Results: The CAD patients’ average age was 66.3 ± 10.7 years, while 65.5 ± 12.0 years in controls. The frequencies of APOE allele ɛ3, ɛ4, and ɛ2 were 83.01%, 10.08%, and 6.91% respectively. There were statistically significant differences in genotype ɛ3/ɛ4 (χ2 = 8.077, p = 0.005) in CAD patients compared with the controls. The SLCO1B1 genotype *1b/*1b and haplotype *1b showed the highest frequency in the study sample. Moreover, ε4 carriers had significantly lower HDL‐C, Apo‐A1 levels than ε3 carriers among CAD patients, while ε2 carriers showed lower LDL‐C, Apo‐B level, and higher Apo‐A1/Apo‐B level than ε3 and ε4 carriers. In controls, ε2 carriers showed lower LDL‐C and Apo‐B level, higher Apo‐A1, and Apo‐A1/Apo‐B level than ε4 carriers. Logistic regression analysis showed that high LDL‐C and Apo‐B level, low HDL‐C level, smoking, and the ε4 allele were risks for the presence of CAD.Conclusions: APOE ε4 allele may be associated with susceptibility to CAD in southern Chinese Hakka population. It indicated that the APOE SNPs rs429358 and rs7412 are associated with CAD, but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene.Keywords
This publication has 56 references indexed in Scilit:
- Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery diseaseCardiovascular Diabetology, 2012
- The Genetics of the Human APOE PolymorphismRejuvenation Research, 2011
- Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology, 2009
- Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han populationPharmacogenetics and Genomics, 2009
- Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parametersMolecular Biology Reports, 2008
- ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMSDrug Metabolism and Disposition, 2005
- Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Apolipoprotein E: Far More Than a Lipid Transport ProteinAnnual Review of Genomics and Human Genetics, 2000
- Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988